Dr. Dubinsky is a graduate of the six year BA/MD program at the University of Missouri - Kansas City School of Medicine. He received his Bachelor's degree with a dual degree in History and Biology in 1981 and his MD degree in 1982. He completed an internship in internal medicine at Baylor College of Medicine, Houston, Texas, followed by a neurology residency at the Baylor College of Medicine. Following that, Dr. Dubinsky served a two year fellowship in human motor control under the auspices of Mark Hallet, M.D., in the Clinical Neurology Branch of the National Institute of Neurological, Communicative Disorders and Strokes, National Institutes of Health, Bethesda, Maryland. Following this fellowship, he joined the faculty of the University of Kansas Medical Center and founded the Dystonia Clinic.
Dr. Dubinsky is Board certified in adult neurology by the American Board of Psychiatry and Neurology with added qualifications in Clinical Neurophysiology. He is also certified by the American Board of Electrodiagnostic Medicine. He is a Fellow of the American Academy of Neurology. Dr. Dubinsky has served for six years on the Quality Standards subcommittee of the American Academy of Neurology being active in the preparation and evaluation of practice parameters. He now serves on the Technology and Therapeutics Assessment committee of the American Academy of Neurology and is Chair of the Practice Issues Review Panel of the American Association of Electrodiagnostic Medicine.
Dr. Dubinsky has published in the areas of neurophysiology, PET scanning, the use of botulinum and neurotoxins for the treatment of movement disorders, of which he is one of the early investigators into the use of these toxins, the treatment of movement disorders, and in evidence based medicine. He is currently a graduate student in the Master's of Public Health program at the University of Kansas Medical Center. His dissertation is on the analysis of the Medicare minimum data set for nursing homes for the condition, medical and behavioral problems, and cause of death of people with Huntington' Disease.
His clinical interests include the treatment of movement disorders, specifically dystonia, myoclonus, Huntington's Disease, and other movement disorders as well as Parkinson' Disease. He is actively involved in clinical research in Huntington's Disease, Parkinson's Disease, and in dystonia. He is the Associate Director for the Clinical Neurophysiology fellowship program and is active in the performance and analysis of electrodiagnostic studies.
|
Biosketch |
©
The University of Kansas Medical Center